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ABSTRACT 
Background: Minimally invasive (MI) cardiac surgery was introduced to reduce problems 
associated with a full sternotomy. This meta-analysis aimed to investigate the effects of 
minimally invasive cardiac surgery on a range of clinical outcomes.  
Methods: To identify potential studies (randomised/propsective clinical trials) systematic 
searches were carried out. The search strategy included the concepts of “minimally invasive” 
OR “MIDCAB” AND “coronary artery bypass grafting” OR “cardiac surgery”. This was 
followed by a meta-analysis investigating cross-clamp time, cardiopulmonary bypass (CPB) 
time, operation time, ventilation time, intensive care unit (ICU) stay, hospital stay, incidence 
of myocardial infarction and of stroke/neurologic complications. 
Results: Eight studies (9 intervention groups), totalling 596 participants were analysed. MI 
cardiac surgery was associated with a shorter ICU stay mean difference (MD) -0.7 days (95% 
confidence interval (CI) -1.23 to -0.18, p=0.009) and longer cross-clamp MD 6.7 minutes (95% 
CI 1.24 to 12.17, p=0.02), CPB MD 26.68 minutes (95% CI 10.31 to 43.05, p=0.001), and 
operation times MD 55.03 minutes (95% CI 22.76 to 87.31, p=0.0008). However no 
differences were found in the ventilation time MD -3.94 hours (95% CI -8.09 to 0.21, p=0.06), 
length of hospital stay MD -1.14 days (95% CI -3.11 to 0.83, p=0.26) and in the incidence of 
myocardial infarction odds ratio (OR) 1.97 (95% CI 0.49 to 7.9, p=0.34) or stroke / neurologic 
complications OR 0.67 (95% CI 0.11 to 4.05, p=0.66). 
Conclusions: Minimally invasive cardiac surgery is as safe as conventional surgery and could 
reduce costs due to a shorter period spent in ICU. 
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 INTRODUCTION 
Coronary artery bypass grafting (CABG) was first introduced in the 1960s  [1], and, despite 
the rise of percutaneous coronary intervention, remains the standard of care for high risk 
patients including those with diabetes and/or complex left main or triple vessel disease [1-2]. 
The majority of CABG operations still involve a median sternotomy and use 
cardiopulmonary bypass combined with aortic cross-clamping and cardioplegic arrest. This 
can represent a frightening prospect for some patients with regard to having the chest 
‘cracked open’ [1]. Minimally invasive cardiac surgery, where access to the heart is typically 
achieved through a left or right minithoracotomy, may alleviate this problem. The incision is 
smaller and the risks of wound infection following sternal trauma and problems with 
sternum healing are avoided [1]. Other possible benefits of minimally invasive cardiac 
surgery include a reduction in post-operative atrial fibrillation [3], reduced length of hospital 
stay [4] with earlier mobilisation of patients [5] and cost-effectiveness compared to 
traditional on-pump CABG [4]. Surgeons have also stated that anastomosing the left internal 
mammary artery to the left anterior descending artery is easier via minimally invasive 
cardiac surgery via a left minithoracotomy than a median sternotomy [6]. 
Minimally invasive cardiac surgery is not without its problems. Inadequacy of heart 
exposure with a left minithoracotomy may account for an increase in operation time and 
perioperative complications [7]. In the short term, patients may experience more pain due 
to involvement of the intercostal nerves [3] and excessive rib retraction [8]. The procedure 
is also more technically demanding [9]. One study has also reported that minimally invasive 
surgery increases ventilation time [5], although it should be noted that the majority of cases 
report shorter ventilation times [9-12]. 
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The aims of this meta-analysis were to: i) investigate the effects of minimally invasive 
cardiac surgery on a range of clinical outcomes including cross-clamp time, cardiopulmonary 
bypass time, operation time, ventilation time, ICU and hospital stay, incidence of peri-
operative myocardial infarction, and incidence of stroke/neurologic complications; and ii) 
relate these findings to established thresholds of clinical significance and provide an 
evidence based context for the use of minimally invasive cardiac surgery. 
 
METHODS 
Search strategy 
To identify potential studies systematic searches were carried out using the following 
databases: EMBASE, PubMed, Web of Science and the Cochrane Central Registry of 
Controlled Trials (CENTRAL). The search was supplemented by scanning the reference lists of 
eligible studies. The search strategy included the key concepts of “minimally invasive” AND 
“coronary artery bypass grafting” OR “MIDCAB” OR “cardiac surgery”. All identified papers 
were assessed independently by two reviewers. A third reviewer was consulted to resolve 
disputes. Searches of published papers were conducted up until April 1st, 2016. 
Types of studies to be included and excluded 
Only randomized controlled trials (RCTs) and prospective trials of patients undergoing 
minimally invasive cardiac surgery vs. surgery via a median sternotomy were included. There 
were no language restrictions. Animal studies, review papers and retrospective trials were 
excluded. Studies that did not have any of the desired outcome measures were excluded. 
Incomplete data, or data from an already included study, were excluded. Other treatment 
Accepted on 16th August 2016 
modalities and interventions for coronary artery disease such as percutaneous coronary 
intervention were excluded. Other treatment modalities for valvular disease such as balloon 
valvuloplasty were excluded. 
Participants/population 
This meta-analysis analysed RCTs and prospective trials of both male and female adult (≥18 
years) patients with coronary artery disease or valvular disease who were undergoing 
cardiac surgery using either minimally invasive cardiac surgery or cardiac surgery through a 
median sternotomy.  
Intervention(s), exposure(s) 
This meta-analysis considered all RCTs and prospective trials where patients with stable 
angina or acute coronary syndrome being treated with CABG or patients with valvular 
disease were exposed to either a median sternotomy or minimally invasive surgery. More 
specifically, all RCTs and prospective trials where the intervention of carrying out cardiac 
surgery without the use of a median sternotomy was performed. 
Search Results 
Our initial search found 4,490 articles. Of these 4,345 studies were excluded on the basis of 
title and abstract. 128 studies were excluded as they were not RCTs or prospective trials. Of 
the RCTs and prospective trials we excluded 9 studies: 6 studies that were retrospective 
analyses; 2 studies that had no comparator group; and 1 study that had no reported 
outcomes (see supplementary Figure S1). Eight studies (9 intervention groups) were 
included in our analysis [5, 8-14]. 
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Outcome(s) 
The primary outcomes analysed were: cross-clamp time; cardiopulmonary bypass time; 
operation time; ventilation time; length of stay in the intensive care unit (ICU); length of 
hospital stay; incidence of myocardial infarction; and incidence of stroke / neurologic 
complications. 
Risk of bias (quality) assessment 
The modified JADAD scale was used to assess study quality and reporting [15]. 
Strategy for data synthesis 
Odds ratios were calculated for dichotomous data. Mean differences were calculated for 
continuous data. Meta-analyses were completed for continuous data by calculating the 
mean difference between intervention and control groups from post-intervention data only. 
It is an accepted practice to only use post-intervention data for meta-analysis, but this 
method assumes that random allocation of participants always creates intervention groups 
matched at baseline for age, disease severity. All analyses were conducted using Revman 
5.0 (Nordic Cochrane Centre, Denmark). A fixed effects inverse variance model was used 
unless heterogeneity was >75%, then a random effects model was used. Heterogeneity was 
quantified using the I2 test [16]. We used a 5% level of significance and 95% confidence 
intervals; figures were produced using Revman 5.3. 
RESULTS 
The 8 studies (9 intervention groups) [5, 8-14] included in the analyses had an aggregate of 
596 participants, 298 of which had minimally invasive cardiac surgery and 298 had 
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conventional cardiac surgery via a median sternotomy. Table 1 summarizes the 
characteristics of the included studies. Supplementary Table S1 lists the excluded trials and 
reasons for exclusion. 
Cross-clamp time 
Five studies reported the cross-clamp time in minutes. The mean difference (MD) for the 
pooled analysis was MD 6.7 minutes (95% confidence interval (CI) 1.24 to 12.17, I2=91%, 
p=0.02), see Figure 1. Cross-clamp times were significantly longer in the minimally invasive 
group.  
Cardiopulmonary Bypass Time 
Five studies reported the cardiopulmonary bypass (CPB) time in minutes. The mean 
difference for the pooled analysis was MD 26.68 minutes (95% CI 10.31 to 43.05, I2 = 96%, 
p=0.001), see Figure 2. CPB times were significantly longer in the minimally invasive group.  
Operation time 
Four studies (5 intervention groups) reported the operation time in minutes. The mean 
difference for the pooled analysis was MD 55.03 minutes (95% CI 22.76 to 87.31, I2=95%, 
p=0.0008), see Figure 3. Minimally invasive cardiac surgery operations took a significantly 
longer time to complete compared to conventional cardiac surgery.   
Ventilation time 
Seven studies (8 intervention groups) reported the ventilation time in hours. The mean 
difference for the pooled analysis was -4.68 hours (95% CI -9.27 to -0.1, I2=98%, p=0.05), see 
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Figure 4. There was a strong trend towards a shorter ventilation time in patients operated 
on by minimally invasive cardiac surgery; however, this failed to reach significance.  
Length of ICU stay 
Six studies reported the length of ICU stay in days. The mean difference for the pooled 
analysis was MD -0.7 days (95% CI -1.23 to -0.18, I2=92%, p=0.009), see Figure 5. Patients 
operated on by minimally invasive cardiac surgery had significantly shorter stays in ICU 
compared to those operated on by conventional median sternotomy.  
Length of hospital stay 
Five studies reported the length of hospital stay in days. The mean difference for the pooled 
analysis was -1.14 days (95% CI -3.11 to 0.83, I2=95%, p=0.26), see Figure 6. Although those 
operated on via minimally invasive cardiac surgery had a shorter hospital stay, there was no 
significant difference in the length of hospital stay between the two groups.   
Incidence of myocardial infarction 
Five studies (6 intervention groups) reported the incidence of myocardial infarction. The 
odds ratio for the pooled analysis was OR 1.97 (95% CI 0.49 to 7.9, I2=0%, p=0.34), see 
Figure 7. There was no difference in the incidence of myocardial infarction between patients 
operated on by minimally invasive cardiac surgery compared to those operated on by 
conventional median sternotomy. 
Incidence of stroke / neurologic complications 
Four studies reported the incidence of stroke / neurologic complications. The odds ratio for 
the pooled analysis was OR 0.67 (95% CI 0.11 to 4.05, I2=0%, p=0.66), see Figure 8. There 
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was no difference in the incidence of stroke or neurologic complications between patients 
operated on by minimally invasive cardiac surgery compared to those operated on by 
conventional median sternotomy. 
DISCUSSION 
To the best of our knowledge this is the first systematic review and meta-analysis that 
investigated minimally invasive versus conventional cardiac surgery. The results showed 
that minimally invasive surgery was associated with a significantly shorter stay in the ICU; a 
strong trend towards a shorter intubation time, no significant difference in length of 
hospital stay, whilst the time spent in the operating theatre was longer as was the time 
spent on cardiopulmonary bypass and cross-clamp. There was also no significant difference 
in the incidence of myocardial infarction or stroke/neurological complications. These results 
suggest that minimally invasive surgery has advantages and disadvantages compared to 
conventional surgery including the potential to reduce cost due to a shorter length of time 
spent in ICU. 
Stroke is known to be a major cause of morbidity and mortality following CABG. The 
postoperative incidence of stroke ranges from 1.4 to 3.8% [17]. Risk factors that have been 
identified include prolonged cardiopulmonary bypass (CPB) time and postoperative atrial 
fibrillation [18]. CPB time was significantly longer in the minimally invasive group (see Figure 
1), however the incidence of stroke or neurologic complications was not significantly 
different (Figure 6). In addition, in two separate studies Dogan et al [5, 8] examined 
neuropsychological function and found no difference between the minimally invasive versus 
conventional groups. Only one study reported the incidence of atrial fibrillation [11] where 
the occurrence was similar in both groups and there was no incidence of stroke in either 
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group. These findings suggest that minimally invasive surgery is not associated with a higher 
incidence of stroke / neurologic complications, despite the longer cross-clamp, CPB and 
operation times. These longer times may reflect the greater technical difficulty involved in 
performing minimally invasive cardiac surgery. It should be noted that in four of the studies 
[9-12] off-pump cardiac surgery was performed; this completely removed the risk of long 
CPB and cross-clamp times and minimised aortic manipulation. 
Minimally invasive surgery was associated with a significantly shorter stay in the ICU unit 
(Figure 3). Indeed in all but one [5] of the studies where length of ICU stay was investigated 
the ICU stay was shorter in the minimally invasive group [8-11, 13-14]. It has been reported 
that an increased stay in ICU is associated with a greater risk of mortality and higher hospital 
costs [19]. Therefore, minimally invasive cardiac surgery has the potential to reduce costs 
and reduce risk of mortality, although it should be noted that the length of hospital stay was 
comparable in the 2 groups. There was also a strong trend towards a reduced ventilation 
time in the MI group. This may lead to a decreased risk of ventilator associated pneumonia 
and airway trauma, and facilitate earlier mobilization and transfer to less stressful step-
down monitored units [20]. 
Perioperative myocardial infarction (MI) is a significant cause of morbidity and mortality 
following coronary artery bypass grafting (CABG) [21]. Diagnostic criteria varies including for 
example enzyme release or electrocardiographic criteria [21]. Perhaps, as a consequence of 
this the incidence of MI also varies between 10.8% [21], 10.8% [22] and 24.1% [23]. 
Irrespective of these differences these studies consistently show a poorer outcome for 
those suffering perioperative MI whether this be in terms of having more cardiac events 
during 30 months of follow-up [22], poorer left ventricular function [23], or higher 30-day 
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mortality [21]. In our meta-analysis the incidence of MI was not significantly different 
between the two groups. This suggests that minimally invasive cardiac surgery is non-
inferior compared to conventional cardiac surgery. 
There are several limitations to this work. All of the continuous measurements were 
associated with high heterogeneity (I2 > 90%). It should be noted that heterogeneity for the 
dichotomous measures was 0%. In addition there were differences in the type of surgery 
performed in the conventional group with some using off-pump methods [9-12] and others 
using on-pump methods [5, 8, 10, 13]. Of those investigators who used on-pump methods 
the application of cardioplegia varied. Dogan et al [5, 8] used cold blood cardioplegia whilst 
Tünerir and Aslan [14] and Gulielmos et al [10] used cold crystalloid cardioplegia and 
Speziale et al [13] did not state which cardioplegia was used. The type of surgery also varied 
from CABG [5, 12, 9-11] to valve replacement [8] to repair of Barlow mitral disease [13] to 
atrial septal defect repair and myxoma excision [14]. All of the studies were small and 
involved <100 patients in each group. The experience of the surgeon was not always 
mentioned. 
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Table 1 – included studies 
Study Surgery Minimally invasive 
approach 
N 
MI (conv) 
Age 
MI (conv) 
% male 
MI (conv) 
Outcome measures 
Dogan et al.  
2003 (8) 
 
Germany 
Aortic valve 
replacement 
Partial upper 
sternotomy 
20 (20) 65.7 ± 1.9 
(64.3 ± 2.9) 
55 (45) Chest tube drainage 
CK 
CK-MB 
Cross-clamp time 
CPB time 
Hospital stay 
ICU stay 
Mortality 
Neuropsychological testing 
NSE 
Post-op pain 
Post-op pulmonary function at 6 days 
Protein S-100B 
Stroke 
Troponin T  
Ventilation time 
Dogan et al. 
2002 (5) 
 
Germany 
CABG 
(multi-vessel) 
Left anterior small 
thoracotomy 
20 (20) 65.2 ± 7.1 
(61.6 ± 7.7) 
90 (85)  C5b-9 
Chest tube drainage 
CK 
CK-MB 
CPB time 
Cross-clamp time 
Hospital stay 
ICU stay 
Mortality 
Myoglobin 
Myeloperoxidase 
Neuropsychological testing  
NSE 
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Post-op pain 
Post-op pulmonary function at 6 days 
Protein S-100B 
Troponin T  
Ventilation time 
Güler et al.  
2001 (9) 
 
Turkey 
CABG 
(single-vessel) 
Left anterior 
minithoracotomy 
21 (18) 52.3 ± 8.6 
(54.1 ± 9.0) 
NR ICU stay 
Mortality 
Myocardial infarction 
Post-op pulmonary function at 2 days 
Pulmonary complications at 2 months 
Ventilation time 
Gulielmos et al. 
(2000) (10) 
 
Germany 
On pump CABG 
(single vessel) 
 
Off pump CABG 
(single vessel) 
Minithoracotomy 
 
 
Minithoracotomy 
10 (10) 
 
 
10 (10) 
59.6 ± 11 
(61.2 ± 10.4) 
 
65.1 ± 10 
(62.9 ± 9.8) 
80 (70) 
 
70 (90) 
CK-MB 
CPB time 
Cross-clamp time 
Cytokines 
Myocardial infarction 
Operation time 
Troponin T 
Ventilation time 
Karpuzoglu et al. 
2009 (11) 
 
Turkey 
 
CABG 
(single vessel) 
Left anterior 
minithoracotomy 
27 (27) 56.1 ± 11.2 
(54.6 ± 8.3) 
81 (78) AF 
CK-MB 
Hospital stay 
ICU stay 
Mortality 
Myocardial infarction 
Stroke 
Ventilation time 
Rogers et al. 
2013 (12) 
 
UK 
CABG 
(multi-vessel) 
Left anterolateral 
thoracotomy 
91 (93) 63.1 ± 8.7 
(66.7 ± 8.0) 
92 (86) Hospital stay (median) 
ICU stay (median) 
Mortality 
Myocardial infarction 
Neurologic complications 
Pain scores 
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Pulmonary function at discharge 
Quality of life scores 
Ventilation time 
Speziale et al. 
2011 (13) 
 
Italy 
Repair of Barlow 
mitral disease 
Right 
minithoracotomy 
70 (70) 53.2 ± 10.4 
(54 ± 10.1) 
59 (61) CPB time 
Cross-clamp time 
Hospital stay 
ICU stay 
Mortality 
Myocardial infarction 
Neurologic complications 
Post-op pain scores 
Ventilation time 
Tünerir & Aslan 
2005 (14) 
 
Turkey 
Valve disease, atrial 
septal defect repair 
and myxoma 
excision 
Right infra-axillary 
minithoracotomy 
29 (30) 42 ± 6 
(44 ± 8) 
24 (33) CPB time 
Cross-clamp time 
Hospital stay 
ICU stay 
Ventilation time 
Abbreviations: AF – atrial fibrillation;  C5b-9 – terminal complement complex; CABG – coronary artery bypass graft surgery;  CK – creatine kinase; CK-MB – 
creatine kinase myocardial band; conv – conventional; CPB time – cardiopulmonary bypass time; ICU – intensive care unit; MI – minimally invasive; NSE – 
neuron-specific enolase; NR – not reported; and post-op – post-operative.  
 
